Odyssean »

S&T Ban shares owned by Odyssean

Quarter-by-quarter ownership of S&T Ban (STBA) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in S&T Ban

Tip: Access up to 7 years of quarterly data

All positions including S&T Ban held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in S&T Ban by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $378k 7.7k 49.08

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding S&T Ban

BlackRock
Vanguard Portfolio Management
Dimensional Fund Advisors
State Street Corporation
Vanguard Capital Management
Charles Schwab Investment Management
Geode Capital Management
American Century Companies
Bank of America Corporation
Northern Trust
Goldman Sachs Group
Two Sigma Investments
Morgan Stanley
Bank of New York Mellon
Bridgeway Capital Management

View all funds holding S&T Ban